397 related articles for article (PubMed ID: 25448114)
1. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
Ricciardi A; Dalton JP; Ndao M
Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
[TBL] [Abstract][Full Text] [Related]
2. A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis.
Ricciardi A; Visitsunthorn K; Dalton JP; Ndao M
BMC Infect Dis; 2016 Mar; 16():112. PubMed ID: 26945988
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the protective immune response induced in mice by immunization with Schistosoma mansoni schistosomula tegument (Smteg) in association with CpG-ODN.
Teixeira de Melo T; Araujo JM; Campos de Sena I; Carvalho Alves C; Araujo N; Toscano Fonseca C
Microbes Infect; 2013 Jan; 15(1):28-36. PubMed ID: 23099420
[TBL] [Abstract][Full Text] [Related]
4.
Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
Front Immunol; 2018; 9():1762. PubMed ID: 30105029
[TBL] [Abstract][Full Text] [Related]
5. Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models.
Torben W; Ahmad G; Zhang W; Siddiqui AA
Vaccine; 2011 Mar; 29(12):2262-71. PubMed ID: 21277404
[TBL] [Abstract][Full Text] [Related]
6. Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine.
Ahmad G; Zhang W; Torben W; Haskins C; Diggs S; Noor Z; Le L; Siddiqui AA
Parasitol Res; 2009 Nov; 105(6):1767-77. PubMed ID: 19809833
[TBL] [Abstract][Full Text] [Related]
7. Adjuvanted
Perera DJ; Hassan AS; Jia Y; Ricciardi A; McCluskie MJ; Weeratna RD; Ndao M
Front Immunol; 2020; 11():605288. PubMed ID: 33304354
[TBL] [Abstract][Full Text] [Related]
8. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
Ahmad G; Zhang W; Torben W; Noor Z; Siddiqui AA
Int J Infect Dis; 2010 Sep; 14(9):e781-7. PubMed ID: 20630783
[TBL] [Abstract][Full Text] [Related]
10. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
[TBL] [Abstract][Full Text] [Related]
11. Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.
Zhang W; Ahmad G; Torben W; Noor Z; Le L; Damian RT; Wolf RF; White GL; Chavez-Suarez M; Podesta RB; Kennedy RC; Siddiqui AA
J Infect Dis; 2010 Apr; 201(7):1105-12. PubMed ID: 20187746
[TBL] [Abstract][Full Text] [Related]
12. Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse.
Zhang W; Ahmad G; Torben W; Siddiqui AA
Parasite Immunol; 2010 Apr; 32(4):252-8. PubMed ID: 20398225
[TBL] [Abstract][Full Text] [Related]
13. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.
Da'Dara AA; Skelly PJ; Walker CM; Harn DA
Parasite Immunol; 2003; 25(8-9):429-37. PubMed ID: 14651590
[TBL] [Abstract][Full Text] [Related]
14. Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.
Molehin AJ; Sennoune SR; Zhang W; Rojo JU; Siddiqui AJ; Herrera KA; Johnson L; Sudduth J; May J; Siddiqui AA
Parasitol Res; 2017 Nov; 116(11):3175-3188. PubMed ID: 29026995
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
[TBL] [Abstract][Full Text] [Related]
16. Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine.
Pacífico LG; Fonseca CT; Chiari L; Oliveira SC
Immunobiology; 2006; 211(1-2):97-104. PubMed ID: 16446174
[TBL] [Abstract][Full Text] [Related]
17. Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni.
Ahmad G; Torben W; Zhang W; Wyatt M; Siddiqui AA
Parasite Immunol; 2009 Mar; 31(3):156-61. PubMed ID: 19222788
[TBL] [Abstract][Full Text] [Related]
18. Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model.
Hassan AS; Zelt NH; Perera DJ; Ndao M; Ward BJ
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007490. PubMed ID: 31790394
[TBL] [Abstract][Full Text] [Related]
19. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
20. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
